Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ProShares UltraShort Bloomberg Crude Oil
SCO
The investment seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Bloomberg Commodity Balanced WTI Crude Oil IndexSM. The index aims to track the performance of 3 separate contract schedules for WTI Crude Oil futures. One-third of the index follows a monthly roll schedule two months beyond the nearby contract....
The second third of the index follows a June annual roll schedule, while the remaining third follows a December annual roll schedule. The index is not linked to the spot price of WTI crude oil.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (ARCA:SCO)
New Post
View:
Posts & Comments
Threaded Posts
(10)
•••
Contra_Man
X
View Profile
View Bullboard History
Comment by
Contra_Man
on Apr 05, 2024 12:09pm
RE:RE:RE:RE:RE:No Oil (or PCE) Volitility
Re-set stopped out positions in SCO-N @ $14.74 to now hold max. o/w 30/15 inventory allocation.
(10)
•••
Contra_Man
X
View Profile
View Bullboard History
Comment by
Contra_Man
on Apr 01, 2024 3:15pm
RE:RE:RE:RE:No Oil (or PCE) Volitility
Added as now filled five (5) SCO-N positions @ $15.72 to now hold max. over-weight 30/15 inventory allocation.
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(10)
•••
Contra_Man
X
View Profile
View Bullboard History
Comment by
Contra_Man
on Mar 28, 2024 2:31pm
RE:RE:RE:No Oil (or PCE) Volitility
Added as now filled five (5) SCO-N positions @ $15.92 to now hold over-weight 25/15 inventory allocation.
(10)
•••
Contra_Man
X
View Profile
View Bullboard History
Comment by
Contra_Man
on Mar 22, 2024 10:48am
RE:RE:No Oil (or PCE) Volitility
Added as now filled five (5) SCO-N @ $ 16.49 to now hold over-weight 20/15 inventory allocation.
(10)
•••
Contra_Man
X
View Profile
View Bullboard History
Comment by
Contra_Man
on Mar 18, 2024 3:36pm
RE:No Oil (or PCE) Volitility
Added as now filled five (5) SCO-N postions @ $16.14 to now hold full 15/15 inventory allocation.
(10)
•••
Contra_Man
X
View Profile
View Bullboard History
Post by
Contra_Man
on Mar 15, 2024 12:38pm
No Oil (or PCE) Volitility
Added as now filled ten (10) SCO-N positions @ $16.61 to now hold 10/15 inventory allocation.
(9)
•••
schoolofrock
X
View Profile
View Bullboard History
Post by
schoolofrock
on Oct 02, 2020 12:01pm
Q3 Energy Industry Report: Exploration and Production
Investors should focus on low-cost producers with good balance sheets. Investors would be wise to ... https://www.channelchek.com/news-channel/Industry_Report___Energy___Exploration
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study